• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Wednesday, November 18, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Novel SLC12A3 Mutations Identified in Gitelman Syndrome Case

by
November 18, 2026
in Health
Reading Time: 3 mins read
0
Novel SLC12A3 Mutations Identified in Gitelman Syndrome Case

Novel SLC12A3 Mutations Identified in Gitelman Syndrome Case

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Researchers have confirmed that two novel compound heterozygous mutations in the SLC12A3 gene are pathogenic, leading to loss-of-function in a patient with Gitelman syndrome. The study, which combined clinical assessment with in vitro functional validation, provides critical evidence for classifying variants of uncertain significance. The findings suggest that these specific mutations disrupt the function of the thiazide-sensitive sodium-chloride cotransporter (NCC) through protein misfolding and impaired cellular trafficking.

Gitelman syndrome is a rare autosomal recessive renal tubulopathy characterized by the loss of function in the SLC12A3 gene. This gene encodes the NCC protein, which is essential for sodium and chloride reabsorption in the distal convoluted tubule of the kidney. While the clinical hallmarks of the condition include hypokalemia, metabolic alkalosis, and hypocalciuria, diagnosing the condition can be difficult due to significant clinical and genetic heterogeneity. When patients present with novel variants of uncertain significance, functional validation becomes necessary to confirm their role in the disease mechanism.

The patient in this study was a 6-year-old boy who presented with growth retardation and was found to have severe hypokalemia, recorded at 2.11 mmol/L, alongside metabolic alkalosis and hypocalciuria. These symptoms provided strong clinical evidence for Gitelman syndrome, prompting further investigation through whole-exome sequencing. This analysis identified novel compound heterozygous variants in the SLC12A3 gene: a missense mutation c.908G > A, resulting in p.Gly303Glu, and a frameshift deletion c.2895delT, resulting in p.Tyr966Thrfs*14.

To assess the pathogenicity of these identified variants, the research team conducted functional studies using HEK293T cells. They transfected these cells with either Wild-type (WT) or mutant NCC constructs to observe the impact of the variants on protein behavior. Bioinformatics analysis initially indicated that both mutations affected highly conserved amino acid residues and were likely pathogenic, providing a strong rationale for the subsequent experimental validation.

The researchers utilized immunofluorescence microscopy to examine the subcellular localization of the NCC proteins. While the Wild-type NCC correctly localized to the plasma membrane, both mutant proteins were found to be retained within the endoplasmic reticulum. This pattern of mislocalization is indicative of Class II mutations, where the proteins fail to reach their functional site within the cell due to intracellular retention, thereby preventing normal ion transport.

Complementary Western blot analysis demonstrated that protein levels for both mutants were significantly reduced compared to the Wild-type levels. This reduction suggests that the mutant proteins are unstable and undergo rapid degradation within the cell. The functional assays further confirmed that the presence of these mutant proteins failed to support intracellular ion homeostasis, reinforcing the conclusion that the variants lead to a complete loss of NCC function.

This study confirms that the c.908G > A and c.2895delT variants are indeed pathogenic, acting through mechanisms of protein misfolding, defective trafficking, and accelerated degradation. By establishing the functional consequences of these specific mutations, this research expands the known mutational spectrum of Gitelman syndrome and highlights the essential role of functional analysis in the accurate clinical classification of variants of uncertain significance.

Subject of Research: Genetic and functional analysis of SLC12A3 mutations in Gitelman syndrome

Article Title: Functional characterization of novel compound heterozygous SLC12A3 mutations in a patient with Gitelman syndrome

Article References: Shen, Z., Liu, X., Shen, Z., Gan, Z., Bian, X., Xu, J.-T., Yi, B., Wang, Z., Xiong, F., & Liu, Q. (2026). Functional characterization of novel compound heterozygous SLC12A3 mutations in a patient with Gitelman syndrome. Orphanet Journal of Rare Diseases. https://doi.org/10.1186/s13023-026-04623-9

Image Credits: AI Generated

DOI: 10.1186/s13023-026-04623-9

Keywords: Gitelman syndrome, SLC12A3, Renal tubulopathy, Genetic variants, Compound heterozygosity, NCC protein, Hypokalemia, Metabolic alkalosis, Hypocalciuria, Protein trafficking, Endoplasmic reticulum, Functional validation, Whole-exome sequencing, Rare disease, Cellular physiology, Variant of uncertain significance, Nephrology research, Genomic medicine

News Source: Juliet Wilcox. (November 18, 2026). Novel SLC12A3 Mutations Identified in Gitelman Syndrome Case. Scienmag.

Tags: cellular physiologycompound heterozygosityendoplasmic reticulumfunctional validationGenetic Variantsgenomic medicineGitelman syndromeHypocalciuriahypokalemiametabolic alkalosisNCC proteinNephrology researchprotein traffickingrare diseaserenal tubulopathySLC12A3variant of uncertain significancewhole-exome sequencing
Share12Tweet7Share2ShareShareShare1

Related Posts

Most Neurological Patients in Munich Die in Hospitals Rather Than Hospices

Most Neurological Patients in Munich Die in Hospitals Rather Than Hospices

November 18, 2026
Study Links Stroke and Autoimmune Disorders Through 12q24 and SH2B3 Gene

Study Links Stroke and Autoimmune Disorders Through 12q24 and SH2B3 Gene

November 18, 2026

Hospital Order Set Boosts Timely Prescribing Across Emergency Surgical Admissions

November 18, 2026

Plastic Waste Identified as Potential Reservoir for Pathogenic Bacterial Transmission

November 18, 2026

POPULAR NEWS

  • Over Forty Percent of Northeast Ethiopian Neonates Experience Early Cord Clamping

    Over Forty Percent of Northeast Ethiopian Neonates Experience Early Cord Clamping

    29 shares
    Share 12 Tweet 7
  • Biomimetic Hydroxyapatite Coating Restores Elastic Modulus in Recycled Aggregate Concrete

    29 shares
    Share 12 Tweet 7
  • Early Shoulder Mobilization Accelerates Initial Motion but Yields Equivalent Annual Outcomes

    29 shares
    Share 12 Tweet 7
  • SGLT2 Inhibitor Use Associated With Lower Proteinuria Rates During Bevacizumab Therapy

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Most Neurological Patients in Munich Die in Hospitals Rather Than Hospices

Study Links Stroke and Autoimmune Disorders Through 12q24 and SH2B3 Gene

Hospital Order Set Boosts Timely Prescribing Across Emergency Surgical Admissions

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 88 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.